Group 1 - A shareholder has filed a class action lawsuit against SelectQuote, Inc. (NYSE: SLQT) on behalf of purchasers and acquirers of its securities during the class period from September 9, 2020, to May 1, 2025 [1] - SelectQuote operates as an insurance broker [1] - The Rosen Law Firm is investigating the allegations related to the lawsuit [1]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of misleading practices related to Medicare insurance plans and illegal kickbacks [3][5][6] Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, regardless of quality [5] - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage insurance plans [5] - SelectQuote allegedly received illegal kickbacks from health insurers to steer beneficiaries towards certain plans, limiting enrollment in competitors' offerings [5] - The company is accused of violating federal laws, including the False Claims Act, due to its conduct [5][6] - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021 [6] Group 2: Impact on Stock and Legal Proceedings - Following the DOJ's allegations, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [6] - Investors are reminded of the October 10, 2025 deadline to seek the role of lead plaintiff in the federal securities class action against SelectQuote [3][7]

Core Points - Investors have until October 10, 2025, to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. [1] - The lawsuit pertains to securities purchased between September 9, 2020, and May 1, 2025, inclusive [1] - The action is currently pending [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the upcoming lead plaintiff deadline on October 10, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought SelectQuote securities during the specified class period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by the deadline [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. Group 2: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements and failed to disclose critical information regarding its business practices, including directing Medicare beneficiaries to insurers that compensated SelectQuote rather than providing unbiased comparisons [4]. - It is claimed that SelectQuote received illegal kickbacks to steer Medicare beneficiaries towards certain insurers, which led to non-compliance with applicable laws and regulations [4]. - The lawsuit asserts that the misleading statements made by SelectQuote resulted in investor damages when the true nature of the company's practices became known [4].

Core Viewpoint - SelectQuote Inc. is under increased legal scrutiny due to a whistleblower lawsuit alleging deceptive sales practices, leading to a significant drop in its stock price and a subsequent class-action lawsuit from investors [1][2][5]. Legal Issues - The U.S. Department of Justice (DOJ) has intervened in a lawsuit claiming SelectQuote misled investors about its business model and regulatory risks, particularly regarding its Medicare Advantage sales practices [1][4][6]. - The lawsuit, Pahlkotter v. SelectQuote Inc. et al., includes investors who purchased shares between September 9, 2020, and May 1, 2025, alleging that the company failed to disclose material risks associated with its sales practices [2][6]. Allegations of Misconduct - The complaint alleges that SelectQuote misrepresented its services as providing unbiased advice while actually directing customers towards higher-commission plans and accepting illegal kickbacks [4][8]. - The DOJ's allegations indicate that SelectQuote received tens of millions of dollars in improper payments from 2016 to 2021, which contributed to discriminatory practices against less profitable customers [4][8]. Market Reaction - Following the DOJ's involvement, SelectQuote's stock price fell nearly 20% in a single day, and shares have declined over 40% in the past six months due to investor concerns about legal exposure and reputational damage [5][6]. Investigative Actions - Hagens Berman, a shareholder rights firm, is investigating whether SelectQuote's revenue was artificially inflated through deceptive practices, emphasizing the seriousness of the DOJ's intervention [7]. - The firm is encouraging investors who suffered losses or have relevant information to come forward, highlighting the potential for whistleblower rewards under the SEC program [7][9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of misleading practices related to Medicare insurance plans, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by October 10, 2025 [4][6]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, regardless of quality [6]. - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage plans and received illegal kickbacks from insurers [6]. - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021, leading to a significant drop in stock price [7]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased SelectQuote securities between September 9, 2020, and May 1, 2025, are encouraged to discuss their legal rights and options [1][4]. - The role of lead plaintiff in the class action is open to any member of the putative class, with the deadline for applications set for October 10, 2025 [8]. - Faruqi & Faruqi is also seeking information from whistleblowers and former employees regarding SelectQuote's conduct [9].

Group 1 - The core point of the news is that SelectQuote, Inc. is facing a securities class action lawsuit for failing to disclose material information during the class period from September 9, 2020, to May 1, 2025, with a deadline for lead plaintiff applications set for October 10, 2025 [1][3] - The U.S. Department of Justice filed a complaint against SelectQuote on May 1, 2025, alleging that the company received "tens of millions of dollars" in illegal kickbacks from health insurance companies from 2016 to at least 2021, which led to a significant drop in the company's stock price by 19.2% to $2.56 per share on the same day [4] - ClaimsFiler is a service that assists retail investors in recovering funds from securities class action settlements, providing resources for investors to register, upload transactional data, and seek legal evaluations [5][6] Group 2 - The lawsuit against SelectQuote includes allegations of conspiracy with major insurers to discriminate against less profitable Medicare beneficiaries and making materially false claims regarding unbiased coverage comparisons [4] - Investors affected by the lawsuit are encouraged to visit ClaimsFiler's website or contact the law firm Kahn Swick & Foti, LLC for legal assistance [2]

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for allegedly receiving illegal kickbacks from health insurance companies and misleading investors about its business practices [6]. Allegation Details - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks for steering Medicare beneficiaries to specific insurance plans [6]. - The lawsuit claims that SelectQuote made materially false statements and failed to disclose adverse facts about its operations, including directing beneficiaries to plans that compensated the company the most, rather than providing unbiased comparisons [6]. Stock Impact - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [6]. Legal Process - Investors who purchased SelectQuote securities between September 9, 2020, and May 1, 2025, have until October 10, 2025, to apply to be appointed as lead plaintiff in the lawsuit [6].

Core Viewpoint - SelectQuote Inc. is under legal scrutiny due to allegations of deceptive sales practices related to its Medicare Advantage plans, leading to a significant drop in its stock price and a class-action lawsuit from investors [1][4][5]. Legal Allegations - The lawsuit, Pahlkotter v. SelectQuote Inc. et al., claims that SelectQuote misled investors about its business model and regulatory risks from September 9, 2020, to May 1, 2025 [2][5]. - Allegations include that SelectQuote misrepresented its sales practices, promoting "unbiased advice" while actually steering customers towards higher-commission plans and accepting illegal kickbacks [3][7]. Market Impact - Following the DOJ's intervention, SelectQuote's stock price fell nearly 20% on May 1, 2025, and has since declined over 40% in the past six months, reflecting investor concerns about legal exposure and reputational damage [4][5]. Investigative Actions - Hagens Berman is investigating whether SelectQuote's revenue was artificially inflated through deceptive practices, indicating that the DOJ's involvement elevates the situation to a serious federal matter [6][8].

Core Points - Rosen Law Firm is reminding purchasers of SelectQuote, Inc. securities from September 9, 2020, to May 1, 2025, about the lead plaintiff deadline on October 10, 2025 [1] - Investors who purchased SelectQuote securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] Legal Action Details - A class action lawsuit has been filed against SelectQuote, alleging that the company made false and misleading statements and failed to disclose critical information regarding its business practices [5] - Specific allegations include directing Medicare beneficiaries to insurers that compensated SelectQuote, not providing unbiased comparisons for Medicare Advantage plans, receiving illegal kickbacks, and being vulnerable to regulatory sanctions [5] Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering hundreds of millions for investors [4] - The firm has been recognized for its performance in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4]